IRIX - Bathi resik saben saham (EPS TTM) IRIDEX Corp.

IRIDEX Corporation relies on external suppliers for optics and circuit boards while maintaining strict control over assembly quality. Net income per share over the last 12 months (TTM) reflects current dynamics, with the metric standing at -0.21. Growth is driven by distribution alliances with clinics, and the careful transportation of laser systems ensures instrument precision upon delivery.

The metric is calculated by dividing the aggregate net income over the last four quarters by the total number of common shares. This metric determines the actual income share per security, reflecting the fundamental stability of the business. For IRIDEX Corporation (IRIX), this signifies the efficiency of commercializing laser systems for the treatment of retinopathy and glaucoma. The TTM fundamental earnings per share trend allows for an assessment of the company's ability to monetize its technologies. Analyzing this chart helps investors recognize risks of declining returns in a timely manner.